Gleevec | search
Click here to view Gleevec news from 60+ newspapers.
Bookmark or Share- Gleevec: Uses, Dosage, Side Effects - Drugs.comGleevec is a targeted therapy cancer treatment used to treat specific types of leukemia (blood cancer), bone marrow disorders, skin cancers and certain tumors of the stomach and digestive system. Gleevec is an oral tablet that is taken once or twice a day.
- Imatinib - WikipediaImatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a small molecule inhibitor targeting multiple tyrosine kinases such as CSF1R, ABL, c-KIT, FLT3, and PDGFR-β.
- Gleevec: 7 things you should know - Drugs.comGleevec is an oral tyrosine kinase inhibitor that may be used to treat Ph+CML, Ph+ALL, and some other conditions. It may cause fluid retention, nausea, pain, headache, or blood abnormalities and increase the risk of infection.
- Gleevec Dosage Guide - Drugs.comThe recommended dose of Gleevec is 400 mg/day for the adjuvant treatment of adult patients following complete gross resection of GIST. In clinical trials, one year of Gleevec and three years of Gleevec were studied. In the patient population defined in Study 2, three years of Gleevec is recommended.
- How Gleevec Transformed Leukemia Treatment - NCIThis story outlines the discovery of imatinib (Gleevec), a ground-breaking drug that transformed the treatment of chronic myelogenous leukemia and sparked the beginnings of precision medicine.
More
